Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why BioCryst Pharmaceuticals Popped Today

TheMotleyFool

0 0

Here's Why BioCryst Pharmaceuticals Popped TodayPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX), a clinical-stage biotech focused on treating rare diseases, popped after the company announced the appointment of a new board member. The stock jumped 15.7% higher in midday trading and ended Monday's session with a 12.9% gain.

Investor-relations departments have to issue a release whenever members of a board of directors come and go, but they rarely move biotech stocks this far. BioCryst's stock soared today because its new board member is Dr. Helen Thackray, the chief medical officer (CMO) of GlycoMimetics (NASDAQ: GLYC).

Image source: Getty Images.

Source Fool.com

Like: 0

BCRX

Share